Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 121 0.00 (0.00%)
As of 04/17/2025 10:49 AM Eastern

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
115
121
50-Day Range
107.84
146.50
52-Week Range
95
151
Volume
32,265 shs
Average Volume
105,585 shs
Market Capitalization
£102.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 160
Consensus Rating
Buy

Company Overview

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
Diaceutics PLC Announces Major Shareholding Change
Diaceutics Expands US Market with New Partnerships
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 123 at the beginning of 2025. Since then, DXRX shares have decreased by 1.6% and is now trading at GBX 121.
View the best growth stocks for 2025 here
.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:DXRX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 160
High Stock Price Target
GBX 160
Low Stock Price Target
GBX 160
Potential Upside/Downside
+32.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
119.71
P/E Growth
N/A
Net Income
£-2,843,065.67
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£26.08 million
Cash Flow
GBX 38.78 per share
Price / Cash Flow
3.12
Book Value
GBX 45.87 per share
Price / Book
2.64

Miscellaneous

Free Float
N/A
Market Cap
£102.12 million
Optionable
Not Optionable
Beta
0.58
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:DXRX) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners